908 Devices (NASDAQ:MASS – Get Free Report) and Plexus (NASDAQ:PLXS – Get Free Report) are both technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.
Institutional and Insider Ownership
88.1% of 908 Devices shares are held by institutional investors. Comparatively, 94.5% of Plexus shares are held by institutional investors. 28.2% of 908 Devices shares are held by company insiders. Comparatively, 1.8% of Plexus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of current recommendations for 908 Devices and Plexus, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| 908 Devices | 1 | 0 | 3 | 0 | 2.50 |
| Plexus | 0 | 1 | 5 | 1 | 3.00 |
Volatility and Risk
908 Devices has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Plexus has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500.
Valuation and Earnings
This table compares 908 Devices and Plexus”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| 908 Devices | $56.20 million | 7.56 | $19.49 million | ($0.95) | -10.82 |
| Plexus | $4.03 billion | 1.61 | $172.88 million | $6.78 | 35.79 |
Plexus has higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than Plexus, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares 908 Devices and Plexus’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| 908 Devices | -56.96% | -12.54% | -8.87% |
| Plexus | 4.03% | 12.46% | 5.57% |
Summary
Plexus beats 908 Devices on 12 of the 15 factors compared between the two stocks.
About 908 Devices
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors. The company was founded in 1979 and is headquartered in Neenah, Wisconsin.
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.
